These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35593225)

  • 1. Snrpb is required in murine neural crest cells for proper splicing and craniofacial morphogenesis.
    Alam SS; Kumar S; Beauchamp MC; Bareke E; Boucher A; Nzirorera N; Dong Y; Padilla R; Zhang SJ; Majewski J; Jerome-Majewska LA
    Dis Model Mech; 2022 Jun; 15(6):. PubMed ID: 35593225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spliceosomopathies and neurocristopathies: Two sides of the same coin?
    Beauchamp MC; Alam SS; Kumar S; Jerome-Majewska LA
    Dev Dyn; 2020 Aug; 249(8):924-945. PubMed ID: 32315467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Craniofacial Defects in Embryos with Homozygous Deletion of
    Beauchamp MC; Boucher A; Dong Y; Aber R; Jerome-Majewska LA
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in SNRPB, encoding components of the core splicing machinery, cause cerebro-costo-mandibular syndrome.
    Bacrot S; Doyard M; Huber C; Alibeu O; Feldhahn N; Lehalle D; Lacombe D; Marlin S; Nitschke P; Petit F; Vazquez MP; Munnich A; Cormier-Daire V
    Hum Mutat; 2015 Feb; 36(2):187-90. PubMed ID: 25504470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Core Splicing Factors EFTUD2, SNRPB and TXNL4A Are Essential for Neural Crest and Craniofacial Development.
    Park BY; Tachi-Duprat M; Ihewulezi C; Devotta A; Saint-Jeannet JP
    J Dev Biol; 2022 Jul; 10(3):. PubMed ID: 35893124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiology of craniofacial and cardiac malformations in a mouse model of
    Kumar S; Bareke E; Lee J; Carlson E; Merkuri F; Schwager EE; Maglio S; Fish JL; Majewski J; Jerome-Majewska LA
    Proc Natl Acad Sci U S A; 2024 Sep; 121(39):e2405523121. PubMed ID: 39292749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebro-costo-mandibular syndrome: Clinical, radiological, and genetic findings.
    Tooley M; Lynch D; Bernier F; Parboosingh J; Bhoj E; Zackai E; Calder A; Itasaki N; Wakeling E; Scott R; Lees M; Clayton-Smith J; Blyth M; Morton J; Shears D; Kini U; Homfray T; Clarke A; Barnicoat A; Wallis C; Hewitson R; Offiah A; Saunders M; Langton-Hewer S; Hilliard T; Davis P; Smithson S
    Am J Med Genet A; 2016 May; 170A(5):1115-26. PubMed ID: 26971886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation in Eftud2 causes craniofacial defects in mice via mis-splicing of Mdm2 and increased P53.
    Beauchamp MC; Djedid A; Bareke E; Merkuri F; Aber R; Tam AS; Lines MA; Boycott KM; Stirling PC; Fish JL; Majewski J; Jerome-Majewska LA
    Hum Mol Genet; 2021 May; 30(9):739-757. PubMed ID: 33601405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects of the spliceosomal gene SNRPB affect osteo- and chondro-differentiation.
    Knill C; Henderson EJ; Johnson C; Wah VY; Cheng K; Forster AJ; Itasaki N
    FEBS J; 2024 Jan; 291(2):272-291. PubMed ID: 37584444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local modulation of the Wnt/β-catenin and bone morphogenic protein (BMP) pathways recapitulates rib defects analogous to cerebro-costo-mandibular syndrome.
    Turner BRH; Itasaki N
    J Anat; 2020 May; 236(5):931-945. PubMed ID: 31884688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disrupted auto-regulation of the spliceosomal gene SNRPB causes cerebro-costo-mandibular syndrome.
    Lynch DC; Revil T; Schwartzentruber J; Bhoj EJ; Innes AM; Lamont RE; Lemire EG; Chodirker BN; Taylor JP; Zackai EH; McLeod DR; Kirk EP; Hoover-Fong J; Fleming L; Savarirayan R; ; Majewski J; Jerome-Majewska LA; Parboosingh JS; Bernier FP
    Nat Commun; 2014 Jul; 5():4483. PubMed ID: 25047197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of craniofacial disorders caused by spliceosomal defects.
    Lehalle D; Wieczorek D; Zechi-Ceide RM; Passos-Bueno MR; Lyonnet S; Amiel J; Gordon CT
    Clin Genet; 2015 Nov; 88(5):405-15. PubMed ID: 25865758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2.
    Li Y; Chen Z; Peng J; Yuan C; Yan S; Yang N; Li P; Kong B
    Oncogene; 2023 Jul; 42(31):2386-2401. PubMed ID: 37391593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations within the spliceosomal gene SNRPB affect its auto-regulation and are causative for classic cerebro-costo-mandibular syndrome.
    Tay YL
    Clin Genet; 2015 Jan; 87(1):32-3. PubMed ID: 25174690
    [No Abstract]   [Full Text] [Related]  

  • 15. SNRPB promotes cervical cancer progression through repressing p53 expression.
    Zhu L; Zhang X; Sun Z
    Biomed Pharmacother; 2020 May; 125():109948. PubMed ID: 32106364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine craniofacial development requires Hdac3-mediated repression of Msx gene expression.
    Singh N; Gupta M; Trivedi CM; Singh MK; Li L; Epstein JA
    Dev Biol; 2013 May; 377(2):333-44. PubMed ID: 23506836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor Sox9 is required for cranial neural crest development in Xenopus.
    Spokony RF; Aoki Y; Saint-Germain N; Magner-Fink E; Saint-Jeannet JP
    Development; 2002 Jan; 129(2):421-32. PubMed ID: 11807034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unfolded protein response regulates ER exit sites via SNRPB-dependent RNA splicing and contributes to bone development.
    Zahoor M; Dong Y; Preussner M; Reiterer V; Shameen Alam S; Haun M; Horzum U; Frey Y; Hajdu R; Geley S; Cormier-Daire V; Heyd F; Jerome-Majewska LA; Farhan H
    EMBO J; 2024 Oct; 43(19):4228-4247. PubMed ID: 39160274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the developmental spliceosomal craniofacial disorder Burn-McKeown syndrome using induced pluripotent stem cells.
    Wood KA; Rowlands CF; Thomas HB; Woods S; O'Flaherty J; Douzgou S; Kimber SJ; Newman WG; O'Keefe RT
    PLoS One; 2020; 15(7):e0233582. PubMed ID: 32735620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate p53 activation during development induces features of CHARGE syndrome.
    Van Nostrand JL; Brady CA; Jung H; Fuentes DR; Kozak MM; Johnson TM; Lin CY; Lin CJ; Swiderski DL; Vogel H; Bernstein JA; Attié-Bitach T; Chang CP; Wysocka J; Martin DM; Attardi LD
    Nature; 2014 Oct; 514(7521):228-32. PubMed ID: 25119037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.